Immunovaccine is looking for partners to develop DPX-0907 following Phase I or II clinical trials.
Partnership and licensing opportunities are also available to use Immunovaccine’s patented DepoVax™ vaccine delivery technology.
For partnering opportunities, please contact:
Ella Korets-Smith at eks.ivt@immunovaccine.com